{"id":50568,"date":"2026-03-11T22:40:00","date_gmt":"2026-03-11T15:40:00","guid":{"rendered":"https:\/\/thaipropertynews.com\/feeds\/?p=50568"},"modified":"2026-03-11T22:40:00","modified_gmt":"2026-03-11T15:40:00","slug":"pierre-fabre-laboratories-is-exploring-the-potential-of-artificial-intelligence-to-launch-a-new-generation-of-clinical-studies-in-dermo-cosmetics","status":"publish","type":"post","link":"https:\/\/thaipropertynews.com\/feeds\/?p=50568","title":{"rendered":"Pierre Fabre Laboratories is exploring the potential of Artificial Intelligence to launch a new generation of clinical studies in dermo-cosmetics"},"content":{"rendered":"<table border=\"0\" cellspacing=\"10\" cellpadding=\"5\" align=\"right\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/2930569\/PIERRE_FABRE_Avene_Logo.jpg?p=medium600\" border=\"0\" alt=\"\" title=\"logo\" hspace=\"0\" vspace=\"0\" width=\"118\"\/><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p class=\"prntac\"><b>From 100 to 600 patients<\/b>: to support patients suffering from acne, Av\u00e8ne, Pierre Fabre Laboratories&#8217; leading brand, is strengthening the robustness of its clinical studies via data augmentation through Artificial Intelligence.<\/p>\n<p><span class=\"legendSpanClass\">TOULOUSE, France<\/span>, <span class=\"legendSpanClass\">March 11, 2026<\/span> \/PRNewswire\/ &#8212; Av\u00e8ne, the leading brand in French pharmacies*, in partnership with Toulouse-based HealthTech company BotDesign, has announced a major breakthrough in the field of clinical studies in dermo-cosmetics.<\/p>\n<div dir=\"ltr\">   <a href=\"https:\/\/mma.prnasia.com\/media2\/2930570\/Avene_Cleanance.jpg?p=medium600\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" title=\"Pierre Fabre Laboratories is exploring the potential of Artificial Intelligence to launch a new generation of clinical studies in dermo-cosmetics\" src=\"https:\/\/mma.prnasia.com\/media2\/2930570\/Avene_Cleanance.jpg?p=medium600\" alt=\"Pierre Fabre Laboratories is exploring the potential of Artificial Intelligence to launch a new generation of clinical studies in dermo-cosmetics\" width=\"400\" height=\"400\" align=\"middle\" data-name=\"url$https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F2930570%2FAvene_Cleanance.jpg\"\/><\/a>   <br \/>   <span>Pierre Fabre Laboratories is exploring the potential of Artificial Intelligence to launch a new generation of clinical studies in dermo-cosmetics<\/span>  <\/div>\n<p>In 2026, Av\u00e8ne will conduct a comparative clinical study to evaluate the efficacy of its new treatment for acne-prone skin, Av\u00e8ne Cleanance Comedomed+, in the maintenance phase following oral isotretinoin treatment in adults suffering from severe to very severe acne.<\/p>\n<p>Av\u00e8ne is renowned for its dermatological expertise, inspired by therapeutic know-how, and has been committed to improving the treatment of skin pathologies since 1990. It is thus becoming the first brand to use Artificial Intelligence in clinical studies for dermo-cosmetics.<\/p>\n<p><b><u>A concrete illustration of Pierre Fabre Laboratories&#8217; &#8220;Supportive Care&#8221; strategy.<\/u><\/b><\/p>\n<p>This study is unique in two ways: due to its scientific ambition and because it fully aligns with the &#8220;supportive care&#8221; strategy of Pierre Fabre Laboratories, launched in 2025.<\/p>\n<p><i>&#8220;We belong to a group that has always been rooted in pharmaceuticals and dermo-cosmetics. Our medical expertise gives us a head start in understanding patients and their pathologies. We are ideally positioned to offer treatment protocols based on the pathology, combining dermo-cosmetics with medication. <\/i>We are already preparing solutions to go further, by developing dermo-cosmetic innovations capable of extending and amplifying the action of the medication or delaying its necessity. Because these are dermo-cosmetics, they can be used over the long term, unlike many drug treatments,&#8221; explains <b>Dr. Gautier Doat, <\/b><b>Eau Thermale Av\u00e8ne Medical Director<\/b><b>.<\/b><\/p>\n<p><b>To continue reading<\/b>, <a href=\"https:\/\/nam11.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fwww.pierre-fabre.com%2Fen%2Fnews%2Favene-artificial-intelligence-clinical-studies-dermo-cosmetics&amp;data=05%7C02%7CAlexandre.oliveira%40cision.com%7Ca73f283cfdd6447c488b08de7dff9541%7C887bf9ee3c824b88bcb280d5e169b99b%7C1%7C0%7C639086733936271706%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=jEp%2B4wwdK2BzxwN4EloV%2BWp4kp7aqpssLLqMymTFq9o%3D&amp;reserved=0\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.pierre-fabre.com\/en\/news\/avene-artificial-intelligence-clinical-studies-dermo-cosmetics<\/a><\/p>\n<p>For more information, visit <u><a href=\"https:\/\/eur03.safelinks.protection.outlook.com\/?url=http%3A%2F%2Fwww.pierre-fabre.com%2F&amp;data=05%7C02%7Cmarc.alias%40pierre-fabre.com%7C64634558e47f41f591e408dc5484efb3%7Ca899d509e790454bb3fe4b581016bdc5%7C0%7C0%7C638478177178076567%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C4000%7C%7C%7C&amp;sdata=vykarJoHBUJ8llpgVQ88ZFy5aX6iSebMzZQyha4ioXg%3D&amp;reserved=0\" target=\"_blank\" rel=\"nofollow\">www.pierre-fabre.com<\/a>,<\/u>\u202f\u202f<u><a href=\"https:\/\/www.linkedin.com\/company\/pierre-fabre\/\" target=\"_blank\" rel=\"nofollow\">@Laboratoires Pierre Fabre<\/a><\/u>,\u00a0<u><a href=\"https:\/\/www.linkedin.com\/company\/pierre-fabre-oncology\/\" target=\"_blank\" rel=\"nofollow\">@Pierre Fabre Oncology<\/a><\/u><\/p>\n<p><b><u>About Eau Thermale Av\u00e8ne<\/u><\/b>:\u00a0<a href=\"https:\/\/www.eau-thermale-avene.fr\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.eau-thermale-avene.fr\/<\/a><\/p>\n<p><b>Press contact<\/b>: Caroline Perdrix Thomas\u00a0<br \/><a href=\"mailto:caroline.perdrix@pierre-fabre.com\" target=\"_blank\" rel=\"nofollow\">caroline.perdrix@pierre-fabre.com<\/a><\/p>\n<p><i>*Source: GERS \u2013 SOG Early \u2013 Pharmacy Channel \u2013 Dermo-cosmetics market definition established by Pierre Fabre laboratories \u2013 Origin: Sell Out \u2013 Cumulative data up to December 2025 in volume (units) and value (revenue inc. taxes).\u00a0<\/i><\/p>\n<p>\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<table border=\"0\" cellspacing=\"10\" cellpadding=\"5\" align=\"right\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/2930569\/PIERRE_FABRE_Avene_Logo.jpg?p=medium600\" border=\"0\" alt=\"\" title=\"logo\" hspace=\"0\" vspace=\"0\" width=\"118\"\/><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p class=\"prntac\"><b>From 100 to 600 patients<\/b>: to support patients suffering from acne, Av\u00e8ne, Pierre Fabre Laboratories&#8217; leading brand, is strengthening the robustness of its clinical studies via data augmentation through Artificial Intelligence.<\/p>\n<p><span class=\"legendSpanClass\">TOULOUSE, France<\/span>, <span class=\"legendSpanClass\">March 11, 2026<\/span> \/PRNewswire\/ &#8212; Av\u00e8ne, the leading brand in French pharmacies*, in partnership with Toulouse-based HealthTech company BotDesign, has announced a major breakthrough in the field of clinical studies in dermo-cosmetics.<\/p>\n<div dir=\"ltr\">   <a href=\"https:\/\/mma.prnasia.com\/media2\/2930570\/Avene_Cleanance.jpg?p=medium600\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" title=\"Pierre Fabre Laboratories is exploring the potential of Artificial Intelligence to launch a new generation of clinical studies in dermo-cosmetics\" src=\"https:\/\/mma.prnasia.com\/media2\/2930570\/Avene_Cleanance.jpg?p=medium600\" alt=\"Pierre Fabre Laboratories is exploring the potential of Artificial Intelligence to launch a new generation of clinical studies in dermo-cosmetics\" width=\"400\" height=\"400\" align=\"middle\" data-name=\"url$https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F2930570%2FAvene_Cleanance.jpg\"\/><\/a>   <br \/>   <span>Pierre Fabre Laboratories is exploring the potential of Artificial Intelligence to launch a new generation of clinical studies in dermo-cosmetics<\/span>  <\/div>\n<p>In 2026, Av\u00e8ne will conduct a comparative clinical study to evaluate the efficacy of its new treatment for acne-prone skin, Av\u00e8ne Cleanance Comedomed+, in the maintenance phase following oral isotretinoin treatment in adults suffering from severe to very severe acne.<\/p>\n<p>Av\u00e8ne is renowned for its dermatological expertise, inspired by therapeutic know-how, and has been committed to improving the treatment of skin pathologies since 1990. It is thus becoming the first brand to use Artificial Intelligence in clinical studies for dermo-cosmetics.<\/p>\n<p><b><u>A concrete illustration of Pierre Fabre Laboratories&#8217; &#8220;Supportive Care&#8221; strategy.<\/u><\/b><\/p>\n<p>This study is unique in two ways: due to its scientific ambition and because it fully aligns with the &#8220;supportive care&#8221; strategy of Pierre Fabre Laboratories, launched in 2025.<\/p>\n<p><i>&#8220;We belong to a group that has always been rooted in pharmaceuticals and dermo-cosmetics. Our medical expertise gives us a head start in understanding patients and their pathologies. We are ideally positioned to offer treatment protocols based on the pathology, combining dermo-cosmetics with medication. <\/i>We are already preparing solutions to go further, by developing dermo-cosmetic innovations capable of extending and amplifying the action of the medication or delaying its necessity. Because these are dermo-cosmetics, they can be used over the long term, unlike many drug treatments,&#8221; explains <b>Dr. Gautier Doat, <\/b><b>Eau Thermale Av\u00e8ne Medical Director<\/b><b>.<\/b><\/p>\n<p><b>To continue reading<\/b>, <a href=\"https:\/\/nam11.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fwww.pierre-fabre.com%2Fen%2Fnews%2Favene-artificial-intelligence-clinical-studies-dermo-cosmetics&amp;data=05%7C02%7CAlexandre.oliveira%40cision.com%7Ca73f283cfdd6447c488b08de7dff9541%7C887bf9ee3c824b88bcb280d5e169b99b%7C1%7C0%7C639086733936271706%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=jEp%2B4wwdK2BzxwN4EloV%2BWp4kp7aqpssLLqMymTFq9o%3D&amp;reserved=0\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.pierre-fabre.com\/en\/news\/avene-artificial-intelligence-clinical-studies-dermo-cosmetics<\/a><\/p>\n<p>For more information, visit <u><a href=\"https:\/\/eur03.safelinks.protection.outlook.com\/?url=http%3A%2F%2Fwww.pierre-fabre.com%2F&amp;data=05%7C02%7Cmarc.alias%40pierre-fabre.com%7C64634558e47f41f591e408dc5484efb3%7Ca899d509e790454bb3fe4b581016bdc5%7C0%7C0%7C638478177178076567%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C4000%7C%7C%7C&amp;sdata=vykarJoHBUJ8llpgVQ88ZFy5aX6iSebMzZQyha4ioXg%3D&amp;reserved=0\" target=\"_blank\" rel=\"nofollow\">www.pierre-fabre.com<\/a>,<\/u>\u202f\u202f<u><a href=\"https:\/\/www.linkedin.com\/company\/pierre-fabre\/\" target=\"_blank\" rel=\"nofollow\">@Laboratoires Pierre Fabre<\/a><\/u>,\u00a0<u><a href=\"https:\/\/www.linkedin.com\/company\/pierre-fabre-oncology\/\" target=\"_blank\" rel=\"nofollow\">@Pierre Fabre Oncology<\/a><\/u><\/p>\n<p><b><u>About Eau Thermale Av\u00e8ne<\/u><\/b>:\u00a0<a href=\"https:\/\/www.eau-thermale-avene.fr\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.eau-thermale-avene.fr\/<\/a><\/p>\n<p><b>Press contact<\/b>: Caroline Perdrix Thomas\u00a0<br \/><a href=\"mailto:caroline.perdrix@pierre-fabre.com\" target=\"_blank\" rel=\"nofollow\">caroline.perdrix@pierre-fabre.com<\/a><\/p>\n<p><i>*Source: GERS \u2013 SOG Early \u2013 Pharmacy Channel \u2013 Dermo-cosmetics market definition established by Pierre Fabre laboratories \u2013 Origin: Sell Out \u2013 Cumulative data up to December 2025 in volume (units) and value (revenue inc. taxes).\u00a0<\/i><\/p>\n<p>\u00a0<\/p>\n<p><!-- \/wp:html --><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":[],"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[1],"tags":[],"class_list":["post-50568","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/50568","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=50568"}],"version-history":[{"count":0,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/50568\/revisions"}],"wp:attachment":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=50568"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=50568"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=50568"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}